Sequenom, Inc. (Nasdaq: SQNM) announced that they have formed an advisory board to focus on retinal diseases and conditions.

This article: 200 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE